ACNM Celebrates World Theranostics Day
On March 31, we celebrate WORLD THERANOSTICS DAY in honor of the first therapeutic administration of radioiodine to a patient on March 31,1941 by Dr. Saul Hertz.
Dr. Hertz’s clinical trial from over 80 years ago initiated the field of molecular therapy, a field that is now undergoing a renaissance and providing benefit to countless patients with thyroid, neuroendocrine, prostate, and a growing number of other diseases.
The American College of Nuclear Medicine celebrates Dr. Hertz and continues growing his legacy of targeted radiotherapy to benefit patients. Please join ACNM in celebration of World Theranostics Day!